A Phase III, Open-Label, Randomized, Active-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 Versus Gemcitabine Plus Cisplatin Chemotherapy in First-Line Treatment of Participants With Unresectable or Metastatic Cholangiocarcinoma With FGFR2 Rearrangement

Brief Summary

Type:
Gastrointestinal - Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03656536

Study #:
STUDY00143439

Start Date:
Jul 25, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03656536

View Complete Trial Details & Eligibility at ClinicalTrials.gov